Intraoperative Nociception and Postoperative Pain

July 10, 2019 updated by: Samsung Medical Center

the Prediction of Postoperative Pain With Surgical Incision Stimulation in the Patients Undergoing Gastrectomy

If the individual patient's pain is assessed and the amount of analgesic needed after surgery is predicted, appropriate injection of pain control and excessive injection of narcotic analgesic can be prevented. Therefore, investigators try to evaluate the relation intraoperative nociception response with postoperative pain score.

In similar anesthetic depth(End tidal sevoflurane 3%) , changes of surgical pleth index values for stimulus of skin incision are thought to reflect the individual nociception characteristics.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Patients who undergoing upper abdominal laparotomy surgery usually experience severe postoperative pain. Previous studies were reported that preoperative pain, young age, high-dose remifentanil, and depression were associated with severe postoperative pain.

However, anesthesia-related studies were either retrospective studies or injected with anesthetic agents in excess of clinical doses to differentiate between groups. There is no objective indicator for prediction severe postoperative pain.The purpose of this study was to investigate the relationship between intraoperative pain response and postoperative pain on standardized surveillance devices.

To maintain the depth of anesthesia, an EEG monitoring device bispectral index (BIS) is used. Also, surgical pleth index (SPI, GE healthcare, Freiburg, Germany) is a noninvasive pain-analgesia balance monitoring device that is commercially available to evaluate the state of pain during general anesthesia. SPI = 100- (0.3 * heart beat interval + 0.7 * photoplethysmographic pulse wave amplitude) is automatically and continuously calculated from the waveform of peripheral oxygen saturation.

In similar anesthetic depth(End tidal sevoflurane 3%) , changes of SPI values for stimulus of skin incision are thought to reflect the individual nociception characteristics. The investigators hypothesized the higher analgesics consumption can predict with high SPI response following incisional stimuli.

Thus, investigators try to evaluate the comparison of two groups ( high fentanyl consumption group vs. low fentanyl consumption group) with intraoperative SPI value (incision and before aurosal) and hemodynamic parameters under End tidal sevoflurane 3%(anesthesia depth, hemodynamically stable and appropriate anesthetic depth based on previous studies were confirmed at the time of skin incision). And the characteristics and emotional status of patients in two groups are compared.

Study Type

Observational

Enrollment (Actual)

50

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 78 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

the 20-80 year old patients who undergoing lapatotomy gastrectomy at samsung medical center

Description

Inclusion Criteria:

-undergoing laparotomy gastrectomy

Exclusion Criteria:

  • cardiac arrythmia
  • allergic history for drugs
  • renal failure (Cr> 1.5 mg/dl)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Case-Only
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
SPI group
All patients who received the liver resection surgery will receive surgical pleth index
All patients applied surgical pleth index at the time of surgical incision, under End tidal Sevoflurane 3%

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The requirement of postoperative analgesics for postoperative 24 hours
Time Frame: postoperative 24 hour
The requirement of postoperative analgesics for postoperative 24 hours (opioid conversion to fentanyl dose mcg)
postoperative 24 hour
The immediate postoperative pain score
Time Frame: postoperative 24 hour
The numeric rating pain score, no pain=0 ~ worst pain=10
postoperative 24 hour
intraoperative nociception score (surgical pleth index)
Time Frame: intraoperative at the time of skin incision
under End tidal sevoflurane 3%, surgical pleth index score following surgical incision
intraoperative at the time of skin incision

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The correlation of requirement of summed postoperative analgesics and intraoperative nociception score
Time Frame: postoperative 1 hour
The consumption of analgesics (opioid conversion to fentanyl dose mcg) and intraoperative surgical pleth index value
postoperative 1 hour
The correlation of highest postoperative pain score and intraoperative nociception score
Time Frame: postoperative 1 hour
The postoperative pain score (numeric rating pain score, no pain=0~ worst pain=10)and intraoperative surgical pleth index score
postoperative 1 hour

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
The expectation of postoperative pain
Time Frame: The day before surgery
The postoperative pain score (numeric rating pain score, no pain=0~ worst pain=10)
The day before surgery
The expectation of analgesics consumption
Time Frame: The day before surgery
less than average, average, more than average
The day before surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 30, 2018

Primary Completion (Actual)

May 20, 2019

Study Completion (Actual)

May 20, 2019

Study Registration Dates

First Submitted

November 27, 2018

First Submitted That Met QC Criteria

November 29, 2018

First Posted (Actual)

December 3, 2018

Study Record Updates

Last Update Posted (Actual)

July 12, 2019

Last Update Submitted That Met QC Criteria

July 10, 2019

Last Verified

November 1, 2018

More Information

Terms related to this study

Other Study ID Numbers

  • SMC2018-11-118

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pain, Postoperative

Clinical Trials on SPI group

3
Subscribe